Toilax (Bisacodyl)

What Is Toilax and What Is It Used For?

Toilax is a stimulant laxative containing bisacodyl that is used for the short-term treatment of occasional constipation. It works by stimulating the muscles of the large intestine (colon) to produce contractions that move stool through the bowel, and by increasing the amount of water and electrolytes retained in the intestinal lumen. Toilax is also used for bowel preparation before medical procedures such as colonoscopy or surgery.

Bisacodyl, the active ingredient in Toilax, belongs to a group of medicines known as stimulant laxatives (also called contact laxatives). It is classified under ATC code A06AB02. When taken orally, bisacodyl is barely absorbed into the bloodstream. Instead, it acts locally on the wall of the large intestine, where it is converted by intestinal enzymes into its active metabolite, bis-(p-hydroxyphenyl)-pyridyl-2-methane (BHPM).

BHPM has a dual mechanism of action. First, it stimulates the nerve endings in the colonic mucosa, triggering peristaltic contractions that propel intestinal contents forward. Second, it promotes the accumulation of water and electrolytes in the intestinal lumen, softening the stool and increasing its volume. This combined effect makes bisacodyl one of the most widely used and well-studied laxatives worldwide.

Toilax is available in two formulations to suit different clinical needs:

• Enteric-coated tablets (5 mg): Designed for oral administration. The enteric coating prevents the tablet from dissolving in the stomach, ensuring the active ingredient is released in the small intestine. Oral tablets typically produce a bowel movement within 6 to 12 hours. When taken at bedtime, you can expect a result the following morning.
• Rectal suspension (10 mg/5 ml): A ready-to-use micro-enema for rectal administration. This form bypasses the upper gastrointestinal tract entirely and acts directly on the rectum and lower colon. The rectal suspension typically produces a bowel movement within 15 to 60 minutes, making it suitable when faster relief is needed.

Common uses of Toilax

Toilax is primarily indicated for:

• Occasional constipation: Short-term relief when dietary measures, increased fluid intake, and physical activity have not been sufficient
• Bowel preparation: Emptying the bowel before diagnostic procedures (such as colonoscopy, barium enema, or radiological examinations) or before surgery
• Conditions requiring easier bowel movements: Such as after certain surgical procedures, in patients with haemorrhoids, or in situations where straining must be avoided

According to the World Health Organization (WHO) and international gastroenterology guidelines, stimulant laxatives like bisacodyl should be considered when first-line measures (dietary fibre, adequate hydration, and physical activity) and osmotic laxatives have proven insufficient. They are recognized as effective and generally well-tolerated for short-term use.

What Should You Know Before Taking Toilax?

Before taking Toilax, you should be aware of several important contraindications and precautions. Do not use Toilax if you have intestinal obstruction, acute inflammatory bowel conditions, severe dehydration, or an allergy to bisacodyl. Toilax should not be used for more than 7 days without medical advice. Avoid taking the tablets with milk, dairy products, or antacids.

Contraindications

You must not take Toilax if you have any of the following conditions:

• Hypersensitivity: Known allergy to bisacodyl or any of the excipients in the formulation
• Intestinal obstruction (ileus): A complete or partial blockage of the bowel that prevents the normal passage of intestinal contents
• Acute surgical abdominal conditions: Including appendicitis or suspected appendicitis
• Acute inflammatory bowel disease: Such as acute flares of Crohn's disease or ulcerative colitis
• Severe abdominal pain with nausea and vomiting: Which may indicate a serious underlying condition requiring surgical evaluation
• Severe dehydration: As stimulant laxatives can worsen fluid and electrolyte losses
• Rare hereditary conditions: Such as galactose intolerance, total lactase deficiency, or glucose-galactose malabsorption (the tablets contain lactose)

Warnings and Precautions

Take special care when using Toilax in the following situations:

• Maximum 7 days of continuous use: Like all stimulant laxatives, Toilax should not be used daily for extended periods. Prolonged or excessive use can lead to fluid and electrolyte imbalances, particularly hypokalaemia (low potassium levels). Chronic hypokalaemia can cause muscle weakness, cardiac arrhythmias, and impaired renal function.
• Atonic colon risk: Long-term overuse of stimulant laxatives may contribute to a condition where the colon becomes dependent on the laxative to function normally, potentially worsening constipation.
• Dizziness and fainting: Some patients have reported vasovagal responses (dizziness, syncope) in association with abdominal cramping caused by bisacodyl. This is more likely in patients who are already dehydrated or debilitated.
• Not for weight management: Toilax must never be used as a weight loss aid. Misuse of laxatives for weight control is medically dangerous and can lead to severe dehydration, electrolyte disturbances, and organ damage.
• Rectal bleeding: If you notice blood in your stool or on toilet paper, stop taking Toilax and consult a doctor promptly. Rectal bleeding may indicate haemorrhoids, anal fissures, or more serious conditions.

Pregnancy and Breastfeeding

There is limited clinical data on the use of bisacodyl during pregnancy. Animal studies have not shown direct harmful effects on the developing foetus. However, as a precautionary measure, Toilax should only be used during pregnancy after consultation with a healthcare provider who can assess whether the benefits outweigh the potential risks.

International guidelines from the European Medicines Agency (EMA) and the British National Formulary (BNF) generally recommend dietary modifications and bulk-forming laxatives (such as psyllium or methylcellulose) as first-line treatments for constipation during pregnancy. Stimulant laxatives may be considered if first-line measures fail.

Bisacodyl can be used during breastfeeding. Clinical studies have shown that the active metabolite BHPM is not excreted in breast milk in clinically significant amounts. The medicine acts locally in the colon and is minimally absorbed into the systemic circulation.

Driving and Operating Machinery

No systematic studies have been conducted on the effects of bisacodyl on driving ability. However, some patients experience dizziness or vasovagal symptoms (lightheadedness, fainting) due to abdominal cramping. If you experience such symptoms, you should avoid driving or operating heavy machinery until they resolve.

Lactose Content

Toilax enteric-coated tablets contain lactose monohydrate as an excipient. Patients with rare hereditary problems of galactose intolerance, total lactase deficiency, or glucose-galactose malabsorption should not take the tablet form. The rectal suspension does not contain lactose and may be a suitable alternative for these patients.

How Does Toilax Interact with Other Drugs?

Toilax can interact with several types of medications. The most important interactions involve drugs that affect stomach acidity (which can damage the enteric coating), diuretics and corticosteroids (which increase the risk of potassium depletion), and cardiac glycosides like digoxin (where low potassium levels can increase toxicity). Always inform your doctor or pharmacist about all medicines you are taking.

Drug interactions with bisacodyl fall into two main categories: substances that affect the enteric coating of the tablet, and substances where the laxative effect of bisacodyl may alter their efficacy or safety profile.

Major Interactions

The most clinically significant interactions involve medications where potassium levels are critical:

• Diuretics (water tablets): Both loop diuretics (furosemide) and thiazide diuretics (hydrochlorothiazide) promote potassium excretion through the kidneys. When combined with bisacodyl, which can cause potassium loss through the bowel, the cumulative effect may lead to clinically significant hypokalaemia. Symptoms include muscle weakness, fatigue, cramps, and in severe cases, cardiac arrhythmias.
• Corticosteroids: Systemic corticosteroids (prednisolone, dexamethasone) can also promote potassium loss. Combined use with bisacodyl increases the risk of electrolyte disturbance. If concurrent use is necessary, serum potassium should be monitored.
• Cardiac glycosides (digoxin): Hypokalaemia enhances the effect of digoxin on the heart, potentially leading to dangerous cardiac arrhythmias. Patients taking digoxin should use stimulant laxatives with particular caution and only under medical supervision. According to the BNF and FDA labeling guidance, serum potassium should be monitored regularly in patients receiving both agents.

Food Interactions

The enteric coating of Toilax tablets is specifically designed to withstand the acidic pH of the stomach (approximately pH 1-3) and dissolve in the more alkaline environment of the small intestine (pH 6-7). Substances that raise gastric pH can compromise this mechanism:

• Milk and dairy products: The calcium and protein content of milk can transiently buffer stomach acid and raise gastric pH, potentially causing premature dissolution of the enteric coating
• Antacids: Aluminium hydroxide, magnesium hydroxide, calcium carbonate, and similar preparations directly neutralize stomach acid
• Proton pump inhibitors (PPIs): Omeprazole, esomeprazole, and similar drugs significantly reduce gastric acid production, raising stomach pH to levels that may dissolve the enteric coating

To minimize these interactions, take Toilax tablets at least 1 hour before or after consuming milk, dairy products, or antacids. If you are taking a PPI, consider taking Toilax at a different time of day (for example, at bedtime if you take the PPI in the morning).

What Is the Correct Dosage of Toilax?

The standard adult dose of Toilax is 1-2 enteric-coated tablets (5-10 mg) taken at bedtime for oral use, or 1 rectal tube (10 mg) for rectal use. Children aged 10 years and older follow the adult dosing. Children aged 2-10 years may take 1 tablet (5 mg) orally or half a rectal tube. Toilax should not be used in children under 2 years of age.

Adults and Children Over 10 Years

Children Aged 2-10 Years

For children between 2 and 10 years of age:

• Oral: 1 tablet (5 mg) at bedtime
• Rectal: Half a tube (approximately 2.5 ml containing 5 mg bisacodyl)

Toilax should not be used in children under 2 years of age. For children under 10 years, use should be under the guidance of a healthcare provider. Always try dietary measures (increased fibre, adequate fluids, physical activity) before resorting to laxatives in children.

Bowel Preparation

For bowel emptying before diagnostic procedures or surgery, the dosage may be adjusted according to the specific preparation protocol prescribed by your doctor. Common bowel preparation regimens involving bisacodyl typically include:

• 2 to 4 tablets (10-20 mg) taken the evening before the procedure, often combined with a bowel lavage solution
• 1 rectal tube may be administered the morning of the procedure for additional bowel emptying

Always follow the specific instructions provided by your healthcare team for bowel preparation. Do not self-administer higher doses without medical guidance.

Important Administration Instructions

• Swallow tablets whole with a sufficient amount of liquid (at least half a glass of water). Do not crush, break, or chew the tablets. The enteric coating is essential for proper drug delivery and for preventing gastric irritation.
• Do not take with milk, dairy products, or antacids within 1 hour before or after the dose, as these substances can dissolve the enteric coating prematurely.
• Rectal suspension instructions: Remove the cap from the tube. Lie on your side with your knees drawn up towards your chest. Gently insert the nozzle into the rectum and squeeze the tube to administer the contents. Remain lying down for a few minutes to allow the suspension to take effect. A bowel movement will typically follow within 15 to 60 minutes.
• Best time to take: For oral tablets, bedtime is ideal as the effect will occur the following morning. The rectal form can be used at any time of day when rapid relief is needed.

Missed Dose

If you forget to take a dose of Toilax, simply take it when you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and continue with your regular dosing schedule. Do not take a double dose to make up for a forgotten one.

Overdose

What Are the Side Effects of Toilax?

Like all medicines, Toilax can cause side effects, although not everyone gets them. The most common side effects are abdominal cramps, abdominal pain, nausea, and diarrhoea. Serious but rare side effects include severe allergic reactions, colitis, and significant dehydration. Stop taking Toilax and seek medical attention immediately if you experience signs of a severe allergic reaction.

The following side effects have been reported with bisacodyl use, classified by frequency according to the standard medical convention (MedDRA):

Most side effects of Toilax are mild and transient, typically resolving on their own as the body adjusts to the medication. Abdominal cramps are the most frequently reported side effect and are a direct consequence of the drug's mechanism of action (stimulating intestinal contractions).

If you experience any side effects that concern you, or if the side effects persist or worsen, consult your doctor or pharmacist. You can also report side effects to your national pharmacovigilance authority to help monitor the safety of this medicine.

How Should You Store Toilax?

Store Toilax tablets below 25 degrees Celsius in a dry place. The rectal suspension should be stored in a refrigerator (2-8 degrees Celsius). Keep all medicines out of the sight and reach of children. Do not use Toilax after the expiry date stated on the packaging.

Storage Conditions by Formulation

• Enteric-coated tablets: Store below 25°C. Keep in the original packaging to protect from moisture and light. Do not store in the bathroom or other humid environments.
• Rectal suspension: Store in a refrigerator at 2-8°C. Do not freeze. Keep in the original tube until ready to use.

General Storage Guidelines

• Keep out of the sight and reach of children. Store medicines in a locked cabinet or high shelf.
• Do not use Toilax after the expiry date printed on the carton and blister/tube. The expiry date refers to the last day of that month.
• Do not use the medicine if you notice any visible signs of deterioration, such as discolouration of the tablets, cracking of the enteric coating, or changes in the consistency of the rectal suspension.
• Disposal: Do not dispose of medicines via household waste or wastewater. Return unused or expired medicines to your pharmacy for safe disposal. This helps protect the environment.

What Does Toilax Contain?

The active ingredient in Toilax is bisacodyl. Each enteric-coated tablet contains 5 mg of bisacodyl. Each tube of rectal suspension contains 10 mg of bisacodyl in 5 ml of solution. The formulations also contain various excipients (inactive ingredients) that serve manufacturing and delivery functions.

Enteric-Coated Tablets (5 mg)

Active ingredient: Bisacodyl 5 mg per tablet.

Excipients (inactive ingredients):

• Lactose monohydrate
• Maize starch
• Macrogol 6000
• Povidone
• Magnesium stearate
• Sucrose
• Talc
• Acacia (gum arabic)
• Methacrylic acid copolymer (enteric coating material)
• Triethyl citrate
• Titanium dioxide (E171)
• Yellow iron oxide (E172)

Appearance: Small, round, yellow enteric-coated tablets approximately 6 mm in diameter.

Rectal Suspension (10 mg/5 ml)

Active ingredient: Bisacodyl 10 mg per 5 ml tube.

Excipients (inactive ingredients):

• Macrogol 400
• Macrogol 3000
• Macrogol 4000
• Citric acid monohydrate
• Sodium citrate
• Purified water

Appearance: A viscous, grey suspension provided in a single-dose plastic tube with a rectal nozzle.